Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Gum Tech International (NasdaqNM:GUMM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Location
246 East Watkins Street
Phoenix, AZ 85004
Phone: (602) 252-1617
Fax: (602) 252-6650
Employees (last reported count): 68
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 6%
·Over the last 6 months:
 · 2 insider sells; 10.0K shares
  (1.9% of insider shares)
·Institutional: 6% (6% of float)
(20 institutions)
·Net Inst. Selling: 20.0K shares (+4.02%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Gum Tech International Inc. researches, develops, manufactures, markets and distributes products in the nutrient and drug delivery systems market. The Company's current operations are divided into two primary groups: Zicam Operations and Gum Operations. Through a joint venture with Zensano Inc., a subsidiary of Zengen, Inc., the Company is engaged in the manufacture, marketing, and distribution of health-related products using a patented nasal gel technology. The initial product marketed by this joint venture and introduced in 1999 was Zicam Cold Remedy, a homeopathic, nasal gel product that has been formulated to reduce the severity and duration of the common cold. The Company develops and manufactures specialty chewing gum products for branded and private label customers, as well as products marketed under the Company's own brand.
More from Market Guide: Expanded Business Description

Financial Summary
GUMM researches, develops, manufactures, markets and distributes products in the nutrient and drug delivery systems market. For the three months ended 3/31/01, revenues increased 77% to $7.1 million. Net loss applicable to Common decreased 78% to $590 thousand. Revenues reflect increased sales of Zicam Cold Remedy due to customer awareness and acceptance of the product. Lower losses also reflect decreased advertising expenses and interest expense.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 1,373; after tax earnings were -1,934. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Edward Faber, 68
Chairman
--  --  
Carl Johnson
Pres, Director
--  --  
William Hemelt, 47
CFO, Exec. VP - Operations, Sec., Treasurer
$103K$54K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:GUMMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Dec-2000
$6.00 
Recent Price$7.72 
52-Week High
on 12-Oct-2000
$17.813
Beta0.30 
Daily Volume (3-month avg)25.7K
Daily Volume (10-day avg)29.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-39.7%
52-Week Change
relative to S&P500
-19.2%
Share-Related Items
Market Capitalization$71.2M
Shares Outstanding9.23M
Float8.70M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$1.27 
Earnings (ttm)-$0.67 
Earnings (mrq)-$0.21 
Sales (ttm)$1.68 
Cash (mrq*)$0.55 
Valuation Ratios
Price/Book (mrq*)6.08 
Price/EarningsN/A 
Price/Sales (ttm)4.59 
Income Statements
Sales (ttm)$15.3M
EBITDA (ttm*)-$7.81M
Income available to common (ttm)-$6.09M
Profitability
Profit Margin (ttm)-48.6%
Operating Margin (ttm)-50.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-46.39%
Return on Equity (ttm)-49.40%
Financial Strength
Current Ratio (mrq*)2.71 
Debt/Equity (mrq*)0.09 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2001
Shares Short1.05M
Percent of Float12.1%
Shares Short
(Prior Month)
1.06M
Short Ratio36.17 
Daily Volume29.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.